Characterization of the Variability Of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Prediabetes
NCT01663207 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2014-07-16
Summary
A multi-year clinical study to improve tools for measuring the function of insulin-producing beta cells in people with type 2 diabetes mellitus.
Conditions
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
collaborator NIH -
Juvenile Diabetes Research Foundation
collaborator OTHER -
Amylin Pharmaceuticals, LLC.
collaborator INDUSTRY - collaborator INDUSTRY
- collaborator INDUSTRY
- collaborator INDUSTRY
- collaborator INDUSTRY
-
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
collaborator INDUSTRY - collaborator INDUSTRY
-
Foundation for the National Institutes of Health
lead OTHER
Principal Investigators
-
George Atiee, MD · ICON Development Solutions
Eligibility
- Min Age
- 30 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2014-04-30
- Completion
- 2014-04-30
Countries
- United States
Study Locations
More Related Trials
-
Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes
NCT01686945 ·Status: COMPLETED ·Phase: PHASE1
-
Insulin Resistance and Insulin Secretion
NCT00073294 ·Status: WITHDRAWN ·Phase: NA
-
A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023)
NCT06699329 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Dulaglutide in Chinese Participants
NCT01667900 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Repeated Administration of Liraglutide on Insulinogenic Indices
NCT02089256 ·Status: COMPLETED ·Phase: PHASE4
-
Insulin Secretion in Diabetes Before and After Glycemic Control
NCT00469833 ·Status: COMPLETED ·Phase: NA
-
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
NCT05067621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function
NCT01790308 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes
NCT01508923 ·Status: COMPLETED ·Phase: PHASE2
-
Modulation of Human Myocardial Metabolism by GLP-1 Dose Response
NCT01607450 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Trial Investigating the Absorption, Metabolism and Excretion After a Single Subcutaneous Dose of [3H]-Semaglutide in Healthy Male Subjects
NCT02060266 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolic Characteristics of Lean Diabetes in Rural and Semi-urban India and in the United States
NCT02987335 ·Status: COMPLETED
-
Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects
NCT01619345 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India
NCT05502562 ·Status: COMPLETED
-
A Study of Oral GLP1RA RGT001-075 in Adults With Type 2 Diabetes
NCT05297045 ·Status: TERMINATED ·Phase: PHASE2
-
Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes
NCT06671340 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Trial to Assess the Effect of Liraglutide on Blood Triglyceride (Fat) Levels After a Meal in Type 2 Diabetics
NCT00993304 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Investigating the Effects of Semaglutide on ß-cell Function in Subjects With Type 2 Diabetes
NCT02212067 ·Status: COMPLETED ·Phase: PHASE1
-
Development of Predictive Biomarkers
NCT03423862 ·Status: COMPLETED
-
Meal Tolerance Trial in Pregnant Women Diagnosed With Gestational Diabetes Mellitus.
NCT02225951 ·Status: TERMINATED ·Phase: NA
-
Effects of Prebiotics on GLP-1 in Type 2 Diabetes
NCT02569684 ·Status: COMPLETED ·Phase: NA
-
The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes
NCT01536665 ·Status: COMPLETED ·Phase: PHASE1
-
Insulin Variance Throughout the Day
NCT01546545 ·Status: COMPLETED
-
Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Malnutrition
NCT05913193 ·Status: COMPLETED
-
A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1
NCT02221323 ·Status: COMPLETED ·Phase: PHASE2